Active Recombinant Human LGALS7

• Cat.No.: LGALS7-744H
• Product Overview: Recombinant Human LGALS7 (Accession # NP_002298) Ser2-Phe136 was produced in E. coli-derived.

Specification

• Source: E. coli
• Species: Human
• Predicted N Terminal: Ser2
• Form: Lyophilized from a 0.2 µm filtered solution in PBS and Betamercaptoethanol with BSA as a carrier protein.
• Bio-activity: Measured by its ability to agglutinate human red blood cells. Hadari, Y.R. et al. (2000) J. Cell Sci. 113:2385.The ED50 for this effect is typically 0.75 - 3 µg/mL.
• Molecular Mass: Recombinant Human LGALS7 has a calculated MW of 15 kDa.
• Purity: >97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).
• Reconstitution: Reconstitute at 200 µg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.
• Tag: Non
• Protein length: Ser2-Phe136

Gene Information

• Gene Name: LGALS7 lectin, galactoside-binding, soluble, 7 [ Homo sapiens ]
• Official Symbol: LGALS7
• Synonyms: LGALS7; lectin, galactoside-binding, soluble, 7; galectin-7; GAL7; galectin 7; LGALS7A; PIG1; TP53I1
• Gene ID: 3963
• mRNA Refseq: NM_002307
• Protein Refseq: NP_002298
• MIM: 600615
• UniProt ID: P47929
• Chromosome Location: 19q13.13